Table 1.
Wild-type infected RK13 cells | ||||||
Act Db | 3 | 6 | 9 | 12 | 15 | 18 |
Exp 1 | 0.74 | 0.73 | 0.64 | 0.73 | 0.66 | 0.76 |
Exp 2 | 0.99 | 0.98 | 0.98 | 0.99 | 0.99 | 0.94 |
Exp 3 | 1.00 | 1.00 | 0.99 | 1.00 | 1.00 | 0.97 |
Avg | 0.91 | 0.90 | 0.87 | 0.90 | 0.88 | 0.89 |
ΔUL4 infected RK13 cells | ||||||
Act Db | 3 | 6 | 9 | 12 | 15 | 18 |
Exp 1 | 0.89 | 0.84 | 0.71 | 0.63 | 0.71 | 0.21 |
Exp 2 | 0.99 | 0.99 | 0.99 | 0.99 | 0.98 | 0.99 |
Exp 3 | 1.00 | 1.00 | 1.00 | 1.00 | 0.99 | 1.00 |
Avg | 0.96 | 0.94 | 0.90 | 0.87 | 0.90 | 0.73 |
Transcript levels normalized to 28S rRNA
Times post-Actinomycin D treatment (hours) added 12 hours post-infection
Exp, experiment; Avg, average